Faculty Collaboration Database

1. Rizzo JD, Rowe SA. Meningism in a ten-month-old infant during OKT3 therapy. J Heart Transplant. 1990;9(6):727-8.

2. SundarRaj N, Rizzo JD, Anderson SC, Gesiotto JP. Expression of vimentin by rabbit corneal epithelial cells during wound repair. Cell Tissue Res. 1992 Feb;267(2):347-56.

3. Rizzo JD, Strom BL, Berlin J. Replacement of central vascular catheters. N Engl J Med. 1993 Feb 11;328(6):445-6.

4. Rizzo JD, Powe NR. Methodological hurdles in conducting pharmacoeconomic analyses. Pharmacoeconomics. 1999 Apr;15(4):339-55.

5. Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol. 1999 Sep;17(9):2811-8.

6. Rizzo JD, Seidenfeld J, Piper M, Aronson N, Lichtin A, Littlewood TJ. Erythropoietin: a paradigm for the development of practice guidelines. Hematology Am Soc Hematol Educ Program. 2001:10-30.

7. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant. 2001;7(11):620-30.

8. Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant. 2001 Feb;27(4):387-96.

9. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, IBMTR Statistical Center of the International Bone Marrow Transplant Registry, Medical College of Wisconcin, Milwaukee, WI, USA, EBMT, Kiel, Germany. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant. 2001 Apr;27(7):689-92.

10. Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML. Transplant registries: guiding clinical decisions and improving outcomes. Oncology (Williston Park). 2001 May;15(5):649-59; discussion 663-4, 666.

11. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001 Nov;28(10):909-15.

12. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant. 2001 Dec;28(11):1001-11.

13. Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM. Autologous stem cell transplantation for small cell lung cancer. Biol Blood Marrow Transplant. 2002;8(5):273-80.

14. Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002 Apr 15;20(8):2118-26.

15. Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood. 2002 Sep 15;100(6):1997-2004.

16. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002 Oct 01;20(19):4083-107.

17. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. 2002 Oct 01;100(7):2303-20.

18. Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? Bone Marrow Transplant. 2003 Mar;31(6):417-21.

19. Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N. Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. Br J Haematol. 2003 Mar;120(5):793-800.

20. Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood. 2003 Mar 01;101(5):2015-23.

21. Rosenblum MD, Bredeson CN, Chang CC, Rizzo JD. Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplant. Am J Hematol. 2003 Apr;72(4):274-7.

22. Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ, Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003 Apr 01;101(7):2476-82.

23. Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2003 Jun;9(6):389-96.

24. Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. Bone Marrow Transplant. 2003 Jul;32(2):151-5.

25. Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol. 2003 Oct 15;21(20):3754-60.

26. Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2003 Oct 15;21(20):3744-53.

27. van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003 Nov 15;102(10):3521-9.

28. Vose JM, Rizzo DJ, Tao-Wu J, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt SA, Herzig RH, Lemaistre CF, McCarthy PL Jr, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, van Biesen K, Horowitz MM. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant. 2004 Feb;10(2):116-27.

29. Loberiza FR, Zhang M, Rizzo JD, Lee SJ, Klein JP, Logan BR, Eapen M, Serna DS, Lemaistre CF, Horowitz MM. Patient and transplant center factors associated with 100D mortality after receiving allogeneic hematopoietic stem cell transplantation (HSCT). J Clin Oncol. 2004 Jul 15;22(14_suppl):6026.

30. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 2004 Jul 15;104(2):579-85.

31. Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood. 2004 Dec 01;104(12):3797-803.

32. Rizzo JD. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy? Best Pract Res Clin Haematol. 2005;18(3):439-48.

33. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005 Jan 20;23(3):599-608.

34. Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood. 2005 Apr 01;105(7):2979-87.

35. Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005 May 15;105(10):3802-11. PMCID: PMC1895092

36. Nanda A, Rizzo JD, Vogelsang GB. A case of retroperitoneal fibrosis in a patient following HSCT. Bone Marrow Transplant. 2005 Jun;35(11):1125-6.

37. Santo Tomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest. 2005 Jul;128(1):153-61.

38. Jones R, Nieto Y, Rizzo JD, Wall D, Wingard JR, McCarthy P Jr, Hahn T, Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. The evolution of the evidence-based review: evaluating the science enhances the art of medicine--statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2005 Nov;11(11):819-22.

39. Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr. Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. Biol Blood Marrow Transplant. 2005 Dec;11(12):988-98.

40. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56.

41. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006 Feb;12(2):138-51.

42. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant. 2006 Feb;37(3):249-61.

43. Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006 May;12(5):541-51.

44. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD, Foley R, Socie G, Carter S, Couriel D, Schultz KR, Flowers ME, Filipovich AH, Saliba R, Vogelsang GB, Pavletic SZ, Lee SJ, Design of Clinical Trials Working Group. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant. 2006 May;12(5):491-505.

45. Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 2006 Dec 15;108(13):4288-90. PMCID: PMC1895450

46. Tomblyn MR, Rizzo JD. Are there circumstances in which phase 2 study results should be practice-changing? Hematology Am Soc Hematol Educ Program. 2007:489-92.

47. Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant. 2007 Jan;13(1):1-25.

48. Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol. 2007 Apr 10;25(11):1403-11.

49. Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. Biol Blood Marrow Transplant. 2007 Jul;13(7):778-89.

50. Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biol Blood Marrow Transplant. 2007 Jul;13(7):844-52.

51. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE, American Society of Clinical Oncology, American Society of Hematology. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008 Jan 01;26(1):132-49.

52. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood. 2008 Jan 01;111(1):25-41.

53. Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D. Allogeneic hematopoietic cell transplantation for metastatic breast cancer. Bone Marrow Transplant. 2008 Mar;41(6):537-45.

54. Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA. Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant. 2008 Sep;14(9):993-1003. PMCID: PMC3321981

55. Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller AM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H, Rowlings P, Serna DS, Horowitz MM, Rizzo JD, Center For International Blood & Marrow Transplant Research (CIBMTR). Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2008 Dec;14(12):1323-33. PMCID: PMC2638759

56. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009 Jan 29;113(5):1175-83. PMCID: PMC2635083

57. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009 Mar;15(3):367-9. PMCID: PMC3110087

58. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009 Apr 09;113(15):3604-11. PMCID: PMC2668845

59. Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009 May 14;113(20):4992-5001. PMCID: PMC2686146

60. Jones RB, Nieto Y, Wall D, Wingard JR, Rizzo JD, McCarthy PL Jr, Oliansky D, Hahn T, ASBMT Steering Committee on Evidence-Based Reviews. Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2009 Jun;15(6):761-2.

61. Loberiza FR Jr, Lee SJ, Freytes CO, Giralt SA, Van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW, Navarro WH, Rizzo JD. Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009 Aug;15(8):903-9. PMCID: PMC2911964

62. Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD. The effect of smoking on allogeneic transplant outcomes. Biol Blood Marrow Transplant. 2009 Oct;15(10):1277-87. PMCID: PMC2768519

63. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol. 2009 Oct;147(1):129-39. PMCID: PMC2748179

64. Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 2009 Nov;15(11):1455-64. PMCID: PMC2913553

65. Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT, Workshop Participants. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol. 2009 Dec;124(6):1152-60.e12. PMCID: PMC2831471

66. Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Rizzo JD. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009 Dec;15(12):1543-54. PMCID: PMC2775819

67. Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT. Impending challenges in the hematopoietic stem cell transplantation physician workforce. Biol Blood Marrow Transplant. 2009 Dec;15(12):1493-501.

68. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009 Dec;15(12):1628-33. PMCID: PMC2861656

69. Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant. 2010 Jan;16(1):35-45. PMCID: PMC2929576

70. Somerfield MR, Rizzo JD. Can a modest exercise program really improve physical functioning and quality of life among recipients of hematopoietic SCT? Bone Marrow Transplant. 2010 Feb;45(2):217-8.

71. Murphy EA, Ferguson SS, Omondi NA, Getzendaner LC, Gajewski JL, Goldstein GA, Wingard JR, Rizzo JD, Majhail NS. The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010 Feb;16(2):147-56.

72. Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, Wingard JR. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant. 2010 Feb;16(2):207-14. PMCID: PMC2819641

73. Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402. PMCID: PMC2833344

74. Loberiza FR Jr, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Maziarz RT, Rizzo JD, Majhail NS. Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. Biol Blood Marrow Transplant. 2010 Mar;16(3):368-75. PMCID: PMC2822013

75. Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 2010 Mar 04;115(9):1850-7. PMCID: PMC2832815

76. Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol. 2010 Apr 10;28(11):1888-95. PMCID: PMC2860369

77. O'Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D, Leitman S, Anderlini P, Donor Health and Safety Working Committee from Center for International Blood and Marrow Transplant Research (CIBMTR). Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. Blood. 2010 Jun 17;115(24):5097-101. PMCID: PMC2890146

78. Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer. 2010 Jul 15;116(14):3469-76. PMCID: PMC3153958

79. Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant. 2010 Aug;16(8):1099-106. PMCID: PMC2897953

80. Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JD. Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2010 Aug;16(8):1070-5. PMCID: PMC3144674

81. Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant. 2010 Oct;16(10):1442-50. PMCID: PMC2933950

82. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S. American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract. 2010 Nov;6(6):317-20. PMCID: PMC2988667

83. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010 Nov 18;116(20):4045-59.

84. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Clinical Oncology, American Society of Hematology. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol. 2010 Nov 20;28(33):4996-5010.

85. Wingard JR, Huang IC, Sobocinski KA, Andrykowski MA, Cella D, Rizzo JD, Brady M, Horowitz MM, Bishop MM. Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010 Dec;16(12):1682-92. PMCID: PMC2975785

86. Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringdén O, Weisdorf DJ, Rizzo JD. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone Marrow Transplant. 2011 Jan;46(1):34-43. PMCID: PMC3169009

87. Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011 Jan 06;117(1):316-22. PMCID: PMC3037753

88. Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, Horwitz EM, Veys P, Bonfim C, Al-Seraihy A. Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. Mol Genet Metab. 2011 Feb;102(2):111-5. PMCID: PMC3367500

89. Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2011 Feb;17(2):157-66. PMCID: PMC3017731

90. Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol. 2011 Mar 01;29(7):805-13. PMCID: PMC3068057

91. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. Bone Marrow Transplant. 2011 Mar;46(3):385-92. PMCID: PMC2978251

92. Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2011 May;17(5):737-44. PMCID: PMC3035737

93. Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011 Jun 01;29(16):2230-9. PMCID: PMC3107742

94. Majhail NS, Murphy EA, Omondi NA, Robinett P, Gajewski JL, LeMaistre CF, Confer D, Rizzo JD. Allogeneic transplant physician and center capacity in the United States. Biol Blood Marrow Transplant. 2011 Jul;17(7):956-61. PMCID: PMC3114271

95. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Lint MT, Wingard JR, Tichelli A. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter. 2012;34(2):109-33. PMCID: PMC3459383

96. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT), Sociedade Brasileira de Transplante de Medula Ossea (SBTMO). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. 2012;5(1):1-30. PMCID: PMC3393086

97. Socié G, Rizzo JD. Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation. Semin Hematol. 2012 Jan;49(1):4-9.

98. Jim HS, Syrjala KL, Rizzo D. Supportive care of hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S12-6. PMCID: PMC3445407

99. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research, American Society for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation, Asia-Pacific Blood and Marrow Transplantation Group, Bone Marrow Transplant Society of Australia and New Zealand, East Mediterranean Blood and Marrow Transplantation Group, Sociedade Brasileira de Transplante de Medula Ossea. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012 Mar;47(3):337-41. PMCID: PMC3393084

100. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT),, Sociedade Brasileira de Transplante de Medula Ossea (SBTMO). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71. PMCID: PMC3279570

101. Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 2012 Apr 26;119(17):3908-16. PMCID: PMC3350357

102. Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2012 Jun;18(6):903-12. PMCID: PMC3874400

103. Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant. 2012 Jun;18(6):861-73. PMCID: PMC3288160

104. Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63. PMCID: PMC3404151

105. Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol Blood Marrow Transplant. 2012 Nov;18(11):1727-33. PMCID: PMC3472079

106. Martinez C, Rizzo JD, Reeves D. Comprehensive stem cell transplant (SCT) outcome data submission. J Clin Oncol. 2012 Dec;30(34_suppl):293.

107. Omondi NA, Ferguson SE, Majhail NS, Denzen EM, Buchanan GR, Haight AE, Labotka RJ, Rizzo JD, Murphy EA. Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents. J Pediatr Hematol Oncol. 2013 May;35(4):289-98. PMCID: PMC3659415

108. Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT. Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2013 Jun;48(6):825-31. PMCID: PMC3606905

109. Majhail NS, Rizzo JD, Hahn T, Lee SJ, McCarthy PL, Ammi M, Denzen E, Drexler R, Flesch S, James H, Omondi N, Pedersen TL, Murphy E, Pederson K. Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013 Jun;48(6):865-71. PMCID: PMC3596484

110. Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, Hale GA, Isola LM, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol. 2013 Jul 01;31(19):2437-49. PMCID: PMC3691359

111. McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. Biol Blood Marrow Transplant. 2013 Jul;19(7):1116-23. PMCID: PMC3694566

112. Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR. Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2013 Sep;19(9):1368-73.

113. Majhail NS, Rizzo JD. Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013 Sep;48(9):1145-51.

114. Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM. Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood. 2013 Sep 12;122(11):1974-82. PMCID: PMC3772501

115. Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. Blood. 2013 Dec 05;122(24):3871-8. PMCID: PMC3854109

116. Pollack J, Schaper K, Renner R, Martinez C, Sorenson S, et al. Extending the Bridg Model with Hematopoietic Cell Transplant Concepts. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. 2014;20(2 Supplement): S207-208.

117. Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn JY, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014 Apr;49(4):477-84. PMCID: PMC4071767

118. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplantation Society of Australia and New Zeland (BMTSANZ), East Mediterrnean Blood and Marrow Transplantation Group (EMBMT), Sociedale Brasileira de Transplante de Medula Ossea (SBTMO). [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. Rinsho Ketsueki. 2014 Jun;55(6):607-32.

119. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014 Jun 05;123(23):3664-71. PMCID: PMC4047501

120. Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med. 2014 Jul 24;371(4):339-48. PMCID: PMC5965695

121. Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM. Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. Bone Marrow Transplant. 2014 Aug;49(8):1016-21.

122. Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ. Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Biol Blood Marrow Transplant. 2014 Oct;20(10):1530-6. PMCID: PMC4163109

123. Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M. Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. Biol Blood Marrow Transplant. 2014 Dec;20(12):1926-31.

124. Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA. Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study. Neurobiol Stress. 2015;2:44-50. PMCID: PMC4476410

125. Renner R, Carlis J, Maiers M, Rizzo JD, O'Neil C, et al. Integration of Hematopoietic Cell Transplantation Outcomes Data.Data integration in the life sciences:...International Workshop,DILS...: proceedings. DILS (Conference). 2015, :139-146.

126. Kenzik K, Huang IC, Rizzo JD, Shenkman E, Wingard J. Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors. Support Care Cancer. 2015 Mar;23(3):797-807. PMCID: PMC4312505

127. Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M. Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2015 Apr;21(4):688-95. PMCID: PMC4359657

128. Cornell RF, Zhong X, Arce-Lara C, Atallah E, Blust L, Drobyski WR, Fenske TS, Pasquini MC, Rizzo JD, Saber W, Hari PN. Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation. Bone Marrow Transplant. 2015 Jul;50(7):914-7.

129. Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, LeRademacher J, Loberiza F, Logan B, Parsons SK, Repaczki-Jones R, Robinett P, Rizzo JD, Murphy E, Denzen EM. National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. Biol Blood Marrow Transplant. 2015 Jul;21(7):1308-14. PMCID: PMC4466059

130. Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015 Jul;50(7):947-53. PMCID: PMC4490016

131. Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. PMCID: PMC4512746

132. Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Jan;51(1):83-8. PMCID: PMC4570237

133. Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW. Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. Clin Cancer Res. 2016 Jan 01;22(1):69-78. PMCID: PMC4703514

134. Majhail NS, Baker KS, Abetti B, Jahagirdar BN, Kamani N, Rizzo JD, Saber W, Salazar L, Schatz B, Syrjala KL, Wingard JR, Denzen EM. Patient and provider preferences: Treatment summary and survivorship care plans after hematopoietic cell transplant. J Clin Oncol. 2016 Jan 20;34(3_suppl):63.

135. Wood WA, Le-Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer. 2016 Jan 01;122(1):91-8. PMCID: PMC4707096

136. Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE. Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. Bone Marrow Transplant. 2016 Sep;51(9):1173-9.

137. Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD, Ammi M, Drexler R, Flesch S, James H, Omondi N, Murphy E, Pederson K, Majhail NS. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. Bone Marrow Transplant. 2016 Sep;51(9):1233-40. PMCID: PMC5014617

138. Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD. Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. Biol Blood Marrow Transplant. 2016 Dec;22(12):2256-2263. PMCID: PMC5116244

139. Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. Bone Marrow Transplant. 2016 Dec;51(12):1602-1604.

140. Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ. Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Biol Blood Marrow Transplant. 2017 Jan;23(1):161-164. PMCID: PMC5182134

141. Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M. Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. Bone Marrow Transplant. 2017 Jan;52(1):147-150.

142. Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M. Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017 Aug;23(8):1295-1302.

143. Hashmi SK, Bredeson C, Duarte RF, Farnia S, Ferrey S, Fitzhugh C, Flowers MED, Gajewski J, Gastineau D, Greenwald M, Jagasia M, Martin P, Rizzo JD, Schmit-Pokorny K, Majhail NS. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report. Biol Blood Marrow Transplant. 2017 May;23(5):717-725. PMCID: PMC5378687

144. Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW. Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017 Oct;141(10):1342-1393.

145. Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN. Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. Am J Hematol. 2017 Oct;92(10):E610-E611.

146. Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR. Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. Biol Blood Marrow Transplant. 2017 Nov;23(11):1955-1960.

147. Shaw, B. E., Brazauskas, R., Millard, H. R., Fonstad, R., Flynn, K. E., Abernethy, A., Vogel, J., Petroske, C., Mattila, D., Drexler, R., Lee, S. J., Horowitz, M. M. and Rizzo, J. D. (2017), Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer. doi:10.1002/cncr.30936

148. Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer. 2017 Dec 01;123(23):4687-4700. PMCID: PMC5693638

149. Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M. Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-<i>versus</i>-host disease: low incidence of lower gastrointestinal tract disease. Haematologica. 2018 Apr;103(4):717-727. PMCID: PMC5865423

150. D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE. Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 Aug;53(8):1079-1082. PMCID: PMC6098949

151. Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, Palmer J, Chow E, Meyer E, Marks D, Mohty M, Inamoto Y, Rodriguez C, Nagler A, Sauter C, Komanduri KV, Pidala J, Hamadani M, Johnston L, Shah N, Shaughnessy P, Hamilton BK, Majhail N, Kharfan-Dabaja MA, Schriber J, DeFilipp Z, Tarlock KG, Fanning S, Curtin P, Rizzo JD, Carpenter PA. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. Biol Blood Marrow Transplant. 2018 Jun;24(6):1119-1124.

152. Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S. Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biol Blood Marrow Transplant. 2018 Aug;24(8):1664-1670.

153. Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer. 2018 May 24;18(1):593. PMCID: PMC5968588

154. Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE. Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. J Pediatr Hematol Oncol. 2019 Apr;41(3):233-237. PMCID: PMC6301126

155. Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018 Nov;74:130-136. PMCID: PMC6219911

156. Denzen EM, Preussler JM, Murphy EA, Baker KS, Burns LJ, Foster J, Idossa L, Moore HK, Payton TJ, Haven D, Jahagirdar B, Kamani N, Rizzo JD, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS. Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 Mar;25(3):562-569. PMCID: PMC6445667

157. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. Haematologica. 2019 Apr;104(4):844-854. PMCID: PMC6442962

158. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. Biol Blood Marrow Transplant. 2019 May;25(5):955-964. PMCID: PMC6511296

159. Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biol Blood Marrow Transplant. 2019 Apr;25(4):827-833.

160. Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2019 Apr;25(4):699-711. PMCID: PMC6453753

161. Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D, Poirel HA, Ayuk F, Beguin Y, Bonifazi F, Gratwohl A, Milpied N, Moore J, Passweg J, Rizzo JD, Spellman SR, Sierra J, Solano C, Sanchez-Guijo F, Worel N, Gusi A, Adams G, Balan T, Baldomero H, Macq G, Marry E, Mesnil F, Oldani E, Pearce R, Perry J, Raus N, Schanz U, Tran S, Wilcox L, Basak GW, Chabannon C, Corbacioglu S, Dolstra H, Kuball J, Mohty M, Lankester A, Montoto S, Nagler A, Styczynski J, Yakoub-Agha I, de Latour RP, Kroeger N, Brand R, de Wreede LC, van Zwet E, Putter H. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant. 2020 Apr;55(4):681-694. PMCID: PMC7113189

162. Renner R, Carlis J, Maiers M, Rizzo JD, O’Neill C, Horowitz M, Gee K, Confer D. Integration of hematopoietic cell transplantation outcomes data : Data standards are not enough Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2015;9162:139-146.

163. Majhail NS, Rizzo JD. Screening and Prevention Guidelines for Hematopoietic Cell Transplant Survivors Blood and Marrow Transplantation Long Term Management: Prevention and Complications. 9 September 2013:55-64.

164. Rizzo JD, Curtis RE, Deeg HJ, Travis LB. Response: Solid cancers after allogeneic hematopoietic cell transplantation Blood. 2009;114(1):225-226.

165. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Miller CB, Rarick MU, Regan DH, Lichtin AE. In reply Journal of Clinical Oncology. 2008;26(18):3098-3100.

166. Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, Horowitz MM, Rizzo JD. Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study. JAMA Oncol. 2020 Apr 01;6(4):486-493. PMCID: PMC6990739

167. Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D, Poirel HA, Ayuk F, Beguin Y, Bonifazi F, Gratwohl A, Milpied N, Moore J, Passweg J, Rizzo JD, Spellman SR, Sierra J, Solano C, Sanchez-Guijo F, Worel N, Gusi A, Adams G, Balan T, Baldomero H, Macq G, Marry E, Mesnil F, Oldani E, Pearce R, Perry J, Raus N, Schanz U, Tran S, Wilcox L, Basak GW, Chabannon C, Corbacioglu S, Dolstra H, Kuball J, Mohty M, Lankester A, Montoto S, Nagler A, Styczynski J, Yakoub-Agha I, de Latour RP, Kroeger N, Brand R, de Wreede LC, van Zwet E, Putter H. Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant. 2020 Apr;55(4):838-839. PMCID: PMC7609270

168. Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Adv. 2020 Feb 11;4(3):467-476. PMCID: PMC7013267

169. Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW. Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia. JNCI Cancer Spectr. 2019 Dec;3(4):pkz073. PMCID: PMC6859844

170. Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM. Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. Biol Blood Marrow Transplant. 2020 Jul;26(7):e161-e166. PMCID: PMC7206419

171. D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM. Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182. PMCID: PMC7404814

172. Hong S, Brazauskas R, Hebert KM, Ganguly S, Abdel-Azim H, Diaz MA, Beattie S, Ciurea SO, Szwajcer D, Badawy SM, Gratwohl AA, LeMaistre C, Aljurf MDSM, Olsson RF, Bhatt NS, Farhadfar N, Yared JA, Yoshimi A, Seo S, Gergis U, Beitinjaneh AM, Sharma A, Lazarus H, Law J, Ulrickson M, Hashem H, Schoemans H, Cerny J, Rizzieri D, Savani BN, Kamble RT, Shaw BE, Khera N, Wood WA, Hashmi S, Hahn T, Lee SJ, Rizzo JD, Majhail NS, Saber W. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. Cancer. 2021 Feb 15;127(4):609-618. PMCID: PMC7855526

173. Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Pawar DS, Hillard CJ, Rizzo JD, D'Souza A, Pasquini M, Coe CL, Irwin MR, Raison CL, Drobyski WR. The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. Transl Psychiatry. 2021 Jan 18;11(1):58. PMCID: PMC7812704

174. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885] (Biology of Blood and Marrow Transplantation (2020) 26/10(1876-1885) (S1083879120304146), (10.1016/j.bbmt.2020.07.005)) Transplantation and Cellular Therapy. 2021.

175. Wingard JR, Ahn KW, Dandoy C, Perales MA, Wood WA, Logan B, Riches M, Rizzo JD. COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum. Transplant Cell Ther. 2021 Jul;27(7):533-539. PMCID: PMC8061634

176. D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM. Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182] (Transplantation and Cellular Therapy (2020) 26/8(e177-e182) (S1083879120302251), (10.1016/j.bbmt.2020.04.013)) Transplantation and Cellular Therapy. 2021.

177. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Oct;26(10):1876-1885. PMCID: PMC7571859

178. Majhail NS, Mau LW, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, LeMaistre CF, Loberiza F, Parsons SK, Repaczki-Jones R, Robinett P, Douglas Rizzo J, Murphy E, Logan B, Le-Rademacher J. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplant. 2020 May;55(5):906-917. PMCID: PMC7202970

179. Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. Br J Haematol. 2006 Mar;132(6):755-69.

180. Elizabeth A Murphy , Navneet S. Majhail , Kevin Scott Baker , Beatrice Abetti , Balkrishna N. Jahagirdar , Naynesh KamaniJ. Douglas Rizzo , Wael Saber , Lizette Salazar , Barry Schatz , Karen Leslie Syrjala , John R. Wingard , Ellen M Denzen. Patient and provider preferences: Treatment summary and survivorship care plans after hematopoietic cell transplant. Journal of Clinical Oncology. DOI: 10.1200/jco.2016.34.3_suppl.63 Journal of Clinical Oncology 34, no. 3_suppl (January 20, 2016) 63-63..

181. Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B. Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplant Cell Ther. 2022 Feb;28(2):112.e1-112.e9. PMCID: PMC8915447

182. D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM. Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. Transplant Cell Ther. 2022 Oct;28(10):715-716.

183. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. Transplant Cell Ther. 2022 Oct;28(10):717.

184. Saccardi R, Putter H, Eikema DJ, Busto MP, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FA, Baldomero H, Beguin Y, de la Cámara R, Cedillo Á, Balari AMS, Chabannon C, Corbacioglu S, Dolstra H, Duarte RF, Dulery R, Greco R, Gusi A, Hamad N, Kenyon M, Kröger N, Labopin M, Lee J, Ljungman P, Manson L, Mensil F, Milpied N, Mohty M, Oldani E, Orchard K, Passweg J, Pearce R, de Latour RP, Poirel HA, Rintala T, Rizzo JD, Ruggeri A, Sanchez-Martinez C, Sanchez-Guijo F, Sánchez-Ortega I, Trnková M, Ferreiras DV, Wilcox L, de Wreede LC, Snowden JA. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant. 2023 Jun;58(6):659-666. PMCID: PMC9995719

185. Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023 Jun;29(6):346.e1-346.e10. PMCID: PMC10239334

186. Bhatt NS, Rizzo JD, Majhail NS. Screening and prevention guidelines for hematopoietic cell transplant survivors Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant: Second Edition. 1 January 2021:80-91.

187. Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA. Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. Bone Marrow Transplant. 2023 Oct;58(10):1089-1095. PMCID: PMC10592419

188. Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, Keegan THM, Morton LM. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018. Transplant Cell Ther. 2024 Feb;30(2):239.e1-239.e11. PMCID: PMC10872486

1. Rizzo JD, Strom BF, Berlin J: Central vascular catheters and infection rates. N Engl J Med 328:445, 1993

2. Rizzo JD: Review of Handbook of Supportive Care in Cancer, Klastersky, Schimpff and Senn, eds. J Natl Cancer Inst 87:1328, 1995

3. Rizzo JD, Cella D, Seidenfeld J: In reply: Letter to the Editor. J Clin Oncol 21:2224-2225.

4. Rizzo JD: Clinical Bone Marrow and Blood Stem Cell Transplantation. [Book Review.] Bone Marrow Transplant 35:319, 2005.

5. Nanda A, Rizzo JD, Vogelsang GB: A Case of Retroperitoneal Fibrosis in a Patient following HSCT. [Letter] Bone Marrow Transplant 35:1125-1126, 2005.

6. Majhail NS, Rizzo JD. Late complications. In: Handbook of hematopoietic stem-cell transplantation; (Wingard J, Gastineau DA, Leather HL, Snyder E, Szczepiorkowski ZM, eds), AABB, MA, USA. [Chapter] In press 2008

7. Majhail NS, Rizzo JD. Screening and prevention guidelines for hematopoietic cell transplant survivors. In: Hematopoietic Stem-Cell Transplantation: A Handbook for Clinicians, 2nd Edition; (Wingard J, Gastineau DA, Leather HL, Snyder E, Szczepiorkowski ZM, eds), AABB, MD, USA. [Chapter 8] 2015 29

1. SundarRaj N, RIZZO JD, Anderson S, Goodman W, Thoft R: Expression of unique cytoskeletal-associated proteins upon activation stromal keratocytes during healing of radial keratotomy wounds. ARVO May, 1988

2. RIZZO JD, Vogelsang V, Krumm S, Mock V, Frink B, Bass E: Outpatient BMT for hematologic malignancies: cost-saving or cost-shifting? Blood 90:417a, 1997

3. RIZZO JD, Stiff P, Elias A: Autologous stem cell transplantation for small cell lung cancer. Proceedings of American Society Clinical Oncology 18:469a, 1999

4. Drobyski WR, Klein JP, Pietryga D, Flomenberg N, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor C, Horowitz MM, Juckett M, RIZZO JD, Bauer D, Burns WH, Casper JT: A comparative analysis of transplant outcomes in patients receiving unrelated versus highly HLA-disparate haploidentical family member donor marrow grafts for the treatment of leukemia. Blood 94:564a, 1999

5. Vose J, RIZZO JD, Wu J, van Besien K, Lazarus H: Autotransplantation for non-hodgkin lymphoma in 1st relapse or 2nd complete remission - prognostic factor analysis. Blood 96:481a, 2000

6. RIZZO JD, Curtis R, Deeg H, Socié G, Travis L, Flowers M, Sobocinski K, Horowitz MM: Solid cancers in survivors of allogeneic bone marrow transplantation (BMT). Blood 96:557a, 2000

7. RIZZO JD, Ostrowsky B, Horowitz MM, Jarvis W, Pearson M: Infection control and vaccination practices at U.S. and Canadian blood and marrow transplant centers. Program/Proceedings of the American Society of Clinical Oncology 20:20a, 2001

8. Williams SF, RIZZO JD, Wu J, Antman K, Horowitz MM: Syngeneic stem cell transplantation in metastatic breast cancer. Biol Blood Marrow Transplant 7:98a, 2001

9. Metayer C, Curtis RE, Sobocinski KA, Horowitz MM, Vose JM, Weisdorf D, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig R, Keating A, Miller C, Nevill TJ, Pecora AL, RIZZO JD, Travis LB, Williams SF: Myelodysplastic syndrome (MDS) and leukemia after autotransplantation for lymphoma: a multicenter case-control study. Program/Proceedings of the American Society of Clinical Oncology 20:7a, 2001

10. Lee SJ, Bishop MM, Odom LC, Hahn EA, Sobocinski KA, RIZZO JD, Brady MJ, Andrykowski M, Socie G, Cella D, Horowitz MM, Wingard JR, the Late Effects Working Committee of the IBMTR/ABMTR: Preventive health behaviors of stem cell transplant survivors. Blood 98:403a, 2001

11. Loberiza FR, Jr, RIZZO JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ: Depressive syndrome and early deaths following stem cell transplantation for hematologic diseases. Blood 98:742a, 2001

12. Schmitz N, Champlin RE, Loberiza FR, Jr, Klein JP, RIZZO JD, Gratwohl A, Horowitz MM, the Histocompatibility and Stem Cell Sources Working Committee of the IBMTR: Long term follow-up of allogeneic blood stem cell and bone marrow transplantation: a collaborative study of EBMT and IBMTR. Blood 98:744a, 2001

13. Serna DS, Zhang MJ, Scott-Baker K, Eapen M, Horowitz MM, Klein JP, Lee SJ, RIZZO JD, Loberiza Jr. FR: Trends in survival rates by race after allogeneic hematopoietic stem cell transplantation for leukemia in the United States and Canada. Blood 100:186a, 2002

14. Navarro WH, Loberiza FR, Bajorunaite R, Lazarus HM, RIZZO JD, van Besien K, Vose JM, Horowitz MM on behalf of the Lymphoma Working Committee of the Autologous Blood and Marrow Transplant Registry (ABMTR). Impact of weight on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation (AHCT). Meeting Proceedings of the American Society of Clinical Oncology 22:832a, 2003.

15. Ueno NT, RIZZO JD, Niederwieser D, Cheng Y, Antman K, Stiff PJ, Demirer T, Horowitz MM for the Solid Tumor Working Committees of the International Bone Marrow Transplant Registry/The European Group for Blood and Marrow Transplantation (IBMTR/EBMT). Review of allogeneic hematopoietic stem cell transplantation (ALLO HSCT) in metastatic breast cancer (MBC). Meeting Proceedings of the American Society of Clinical Oncology 22:832a, 2003

16. Bishop M.M., Hahn E., Cella D., Brady M.J., Andrykowski M.A., Beaumont J, RIZZO JD, Wingard JR. The Gift of Life Comes with a Price: The Impact of Hematopoietic Stem Cell Transplant on the Long-term Quality of Life of Survivors and their Spouses. Paper presented at the Annual BMT Tandem Meeting of the IBMTR/ABMTR and ASBMT, Orlando, FL. Biol Blood Marrow Transplant 10:S7, 2004

17. Bishop M.M., Hahn E., Cella D., Brady M.J., Andrykowski M.A., Beaumont J., RIZZO JD, Wingard J.R. The Gift of Life Comes with a Price: The Impact of Hematopoietic Stem Cell Transplant on the Long-term Quality of Life of Survivors and their Spouses. Psychooncology 13:S62-63, 2004

18. Champlin RE, Loberiza, Jr. FR, Eapen M, RIZZO JD, Bredeson CN, Wagner JE, Horowitz MM on behalf of the Histocompatibility Alternative Stem Cell Sources Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Prevalence of microbially contaminated hematopoietic stem cell products. Blood 104:612a, 2004.

19. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz, MM, Sobocinski, KA, RIZZO JD, Wingard JR. Long-term health-related quality of life (HRQOL), growth and spiritual well-being after hematopoietic stem cell transplantation (HSCT). Presented at the 2nd Annual Conference of the American Psychosocial Oncology Society (APOS), Phoenix, AZ, January, 2005. Psycho-Oncology 14(Supp 1) S21, 2005.

20. Goldman JM, Sobocinski KA, Zhang MJ, Klein JP, Ketelsen SW, Giralt SA, Horowitz, MM, RIZZO JD, for the Chronic Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Long term outcome after allogeneic hematopoietic cell transplantation (HCT) for CML. Biol Blood Marrow Transplant 12:17, 2006.

21. Ueno NT, RIZZO JD, Cheng YC, Childs R, Stiff PJ, Demirer T, Horowitz M.M, Niederwieser D. Allogeneic hematopoietic cell transplantation (allo HCT) for metastatic breast cancer (MBC). Biol Blood Marrow Transplant 12:32, 2006.

22. Graham HJ, Wade JC, RIZZO JD, Hari P, Miels S, Gruling RJ, Sorensen SH. Recognizing indications for photopheresis in acute and chronic graft-versus-host disease patients. Biol Blood Marrow Transplant 12:167, 2006.

23. Hayes-Lattin B, Carreras J, Zhang M-J, van Besien K, Vose JM, Lazarus HM, RIZZO JD, Hari P. Superior survival after autologous vs. allogeneic hematopoietic stem cell transplantation (HCT) for diffuse large B-cell lymphoma (DLBCL) not explained by differences in chemosensitivity. Blood 108:857a, 2006.

24. Joshua TV, RIZZO JD, Zhang M-J, Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and gender. Biol Blood Marrow Transplant 13:22, 2007.

25. Bishop MM, Beaumont JL, Lee SJ, Andrykowski MA, RIZZO JD, Wingard JR. Preventive health behaviors of long-term hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 13:48, 2007.

26. Fenske TS, Hari P, Carreras J, Zhang M-J, Kamble R, RIZZO JD, van Besien K, Lazarus HM, Vose JM on behalf of the Writing Committee. Pre-transplant Rituximab therapy is associated with improved progression-free and overall survival in patients undergoing autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma (DLBCL). Blood 110:116, 2007.

27. Baker KS, Hassebroek A, Ballen K, Bigelow C, Frangoul H, Hardy C, Lee S, Switzer G, RIZZO JD, Klein JP, Majhail N, Davies S. Impact of ethnicity and socioeconomic status on outcome of unrelated donor (URD) Hematopoietic Cell Transplantation (HcT)Blood 110:315, 2007.

28. Navarro WH, Agovi M-A, Logan B, Bacigalupo A, Ballen K, Bolwell B, Frangoul H, Gupta V, Hahn T, Juckett M, Lazarus HM, Litzow M, Liesveld J, Moreb J, Marks D, McCarthy P, RIZZO JD, on behalf of the CIBMTR writing committee. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) in adults. Blood 112:26, 2008.

29. Schriber JR, Agovi M-A, Ballen KK, Bacigalupo A, Hale GA, Gupta V, Lazarus HM, Litzow MR, Marks DI, Giller RH, Maziarz RT, Bornhauser M, Isola LM, Bredeson C, RIZZO JD. Second unrelated donor (URD) transplant as a rescue strategy for 122 patients with primary non-engraftment: results from the CIBMTR. Blood 112:295, 2008.

30. Majhail NS, Wang Z, Zhang M-J, Lazarus HM, Bajorunaite R, RIZZO JD. Long-term survival and late relapse in 2-year survivors of autologous hematopoietic cell transplantation for lymphoma. Biol Blood Marrow Transplant 15:22-23, 2009.

31. O'Donnell P, Pedersen T, Confer D, Pulsipher M, RIZZO JD, Stroncek D, Leitman S, Anderlini P. Practice patterns for evaluation, consent and care of related donors and recipients at hematopoietic stem cell transplant centers in the United States: is conflict-of-interest an unrecognized issue? Biol Blood Marrow Transplant 15:8-9, 2009.

32. Barker CC, Agovi M-A, Logan B, Gupta V, Lazarus HM, Ballen KK, Hale GA, Frangoul H, RIZZO JD, Pasquini MC. Obesity adversely affects survival of pediatric patients with severe aplastic anemia after hematopoietic cell transplantation. Blood 114:271, 2009.

33. Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, RIZZO JD. Long-term survival and late relapse in 5-year survivors of allogeneic hematopoietic-cell transplantation (HCT) for chronic myeloid leukemia (CML) in first chronic phase. Blood 114:1288, 2009.

34. Horan, J Logan BR, Agovi M-A, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, RIZZO JD, Pasquini MC. Reducing the risk for transplant related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? Blood 114:269, 2009.

35. Wingard JR, Majhail NS, Bajorunaite R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, RIZZO JD, Bolwell BJ, Socié G. Long-term survival and late deaths in 2-year survivors of myeloablative allogeneic hematopoietic-cell transplantation for hematologic disorders. Blood 114:215, 2009.

36. Hahn T, McCarthy PL, Hassebroek A, RIZZO JD, Parsons S, Joffe S, Majhail N. Transplant utilization, procedure patterns and patient characteristics in North American transplant centers from 1994-2005. Biol Blood Marrow Transplant 16:S198-S199, 2010.

37. Loren AW, Wang Z, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Sorror ML, Bolwell BJ, Wingard J, Socié G, RIZZO JD, Majhail NS. Pregnancy after hematopoietic-cell transplantation: a report from the late effects committee of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 16:S176, 2010.

38. Majhail NS, Bajorunaite R, Sobecks RM, Wang Z, Jacobsohn DA, Sorror ML, Bolwell BJ, Wingard JR, RIZZO JD, Socié G. Second solid cancers after allogeneic hematopoietic-cell transplantation using busulfan-cyclophosphamide conditioning. Biol Blood Marrow Transplant 16:S176-S177, 2010.

39. Akpek G, Pasquini MC, Agovi MA, Logan B, Cooke KR, Maziarz RT, Gupta V, Lazarus HM, Hale GA, Marks DI, Maharaj D, Popat U, Carabasi M, Bornhaeuser M, Bolwell BJ, Ringden O, Ballen KK, RIZZO JD, McCarthy PL, Ho VT. Spleen status and engraftment after allogeneic hematopoietic stem cell transplantation. Blood 116:1432-1433, 2011.

40. Ballen KK, Klein JP, Pedersen TL, Kurtzberg J, Lazarus HM, LeMaistre CF, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, RIZZO JD, Majhail NS, and for the Health Policy Working Committee of the CIBMTR. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation. Blood 116:104-105, 2010.

41. Hahn T, McCarthy PL, Hassebroek A, Klein JP, RIZZO JD, Parsons S, Joffe S, Majhail NS. Significant improvement in day 100 and 1-year overall survival in patients who underwent myeloablative allogeneic hematopoietic cell transplant in the US or Canada between 1994 and 2005. Blood 116:1442, 2010.

42. Majhail NS, Quinn G, Brazauskas R, Wang Z, Chow E, Gilleece M, Halter J, Joshi S, Pidala J, Bolwell B, Jacobsohn D, Socie G, Sorror M, Wingard JR, RIZZO JD, Loren A. Transplant physician perceptions and practice patterns regarding fertility preservation in hematopoietic-cell transplant (HCT) recipients. Biol Blood Marrow Transplant 17: S240, 2011.

43. McCarthy PL, Hahn T, Hassebroek A, Klein JP, RIZZO JD, Parsons S, Joffe S, Majhail NS. Significant improvement in overall survival in patients who underwent autologous hematopoietic cell transplant in the US or Canada between 1994 and 2005. Blood 116:990, 2011.

44. Stadtmauer EA, Krishnan A, Pasquini MC, Ewell M, Alyea EP, Antin JH, Castro-Malaspina H, Kassim AA, Negrin R, Qazilbash MH, RIZZO JD, Rowley SD, Sahebi F, Somlo G, Vesole DH, Vogl DT, Weisdorf DJ, Geller N, Horowitz MM, Maloney DG, Giralt S. Tandem autologous stem cell transplants with or without maintenance therapy versus single autologous transplant followed by HLA-matched sibling nonmyeloablative allogeneic stem cell transplant for patients with high risk multiple myeloma: results from the BMT CTN 0102 Trial. Blood 116:233-234, 2011.

45. Picozzi V, J Releford J, Faure M, Eastwood D, RIZZO JD. The value of the hematologist: appropriate use of diagnostic endoscopy in microcytic and normocytic anemias (MNA). Blood 118:342a, 2011.

46. McClune B, Pedersen TL, Ahn KW, Warlick ED, Pidala J, Waller EK, RIZZO JD, Cairo MS, Woolfrey A, Artz A, Lazarus HM, Weisdorf DJ. Reduced intensity or non-ablative hematopoietic cell transplantation in older patients with non-Hodgkin lymphoma (NHL): encouraging survival for patients ≥55 years. Blood 118:1015a, 2011.

47. Weisdorf DJ, Zhang MJ, Arora M, RIZZO JD, Horowitz MM, Eapen M. Graft-versus-host disease (GVHD) induced graft-versus-leukemia (GVL) effect: more impact on later relapse and disease-free survival following reduced intensity conditioning. Blood 118:1014a, 2011

48. Bredeson C, Burkart J, Zhu X, Sun Y, LeRademacher J, Pasquini M, Armstrong E, RIZZO JD, Kato K. Chimerism testing with reduced intensity intravenous Busulfan-based conditioning regimens: once is enough. Biol Blood Marrow Transplant 18:S331-S332, 2012.

49. Bredeson C, Burkart J, Sun Y, Zhu X, LeRademacher J, RIZZO JD, Armstrong E, Pasquini M, Kato K. Dose, schedule and PK practices with IV busulfan-based conditioning regimens in a non-inferiority trial: heterogeneous practices but low VOD and TRM. Biol Blood Marrow Transplant 18:S325, 2012.

50. Pederson KA, RIZZO JD, Hahn T, Lee SJ, McCarthy PL, Ammi MS, Denzen EM, Drexler R, Flesch SM, James H, Omondi NA, Pedersen TL, Murphy EA, Majhail NS. Patient and Family Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Study. Biol Blood Marrow Transplant 18:S237-S238, 2012.

51. Cornell RF, Thompson J, Drobyski WR, Fenske TS, Horowitz MM, Palmer JM, Pasquini MC, Saad AA, RIZZO JD, Saber W, Zhang M-J, Zhong X, Hari P. Risk factors and clinical features of autologous graft-versus-host disease/engraftment syndrome after autologous hematopoietic cell (HCT) transplantation. Biol Blood Marrow Transplant 18:S250, 2012

52. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio M, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, RIZZO JD, Horowitz MM, Saber W. Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research. Blood 122:548, 2013

53. Lee SJ, Le-Rademacher J, Jim H, Syrjala KL, Wingard JR, Logan BR, Wu J, Majhail NS, Wood WA, RIZZO JD, Geller NL, Kitko CL, Faber Jr EA, Abidi MH, Slater SE, Horowitz MM, Jacobsen P. Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network BMT CTN 0902. Blood122: 699, 2013

54. Majhail NS, Payton T, Mau LW, Le-Rademacher J, Chitphakdithai P, Ekrich M, Joffe S, Lee SJ, LeMaistre CF, Loberiza Jr FR, Logan BR, Murphy EA, Parsons SK, Repaczki-Jones R, RIZZO JD, Robinett P, Denzen E. Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR). Blood 122:1687, 2013

55. Pulsipher MA, Chitphakdithai P, Logan BR, Switzer GE, Riches M, Moffitt HL, RIZZO JD, Anderlini P, Leitman SF, Vaarni JW, Hays A, Kobusingye H, Miller jp, Drexler RJ, King R, Horowitz MM, Confer DL, Navarro WH. Related PBSC Donors Age > 60 Have High Rates of Baseline and Donation-Related Pain and Slow Recovery: First Report from the Related Donor Safety Study (RDSafe). BMT Tandem Meetings, Dallas TX, USA, March 2014.

56. Kroll TM, Singavi A, Schmidt W, Eastwood D, Drobyski W, Horowitz MM, Palmer J, Pasquini M, RIZZO JD, Saber W, Parameswaran NH, Fenske T. Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and Lymphoma. BMT Tandem Meetings, Dallas TX, USA, February 2014.

57. Pollack J, Schaper K, Renner R, Martinez C, Sorensen S, Milius B, O’Neill C, Jones RB, RIZZO JD. Extending the Bridg Model with Hematopoietic Cell Transplant Concepts. BMT Tandem Meetings, Dallas TX, USA, February 2014.

58. Saber W, Cutler C, Nakamura R, Zhang MJ, Atallah E, RIZZO JD, Maziarz RT, Cortes JE, Kalaycio M, Horowitz MM. Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR). Blood 120:355a, 2012

59. Pasquini MC, Logan BR, Ho VT, McCarthy, PL Jr., Cooke KR, RIZZO JD, Zhu X, Sorror ML. Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI. Blood 120:814a, 2012

60. Sorror ML, Logan BR, Zhu X, RIZZO JD, Cooke KR, McCarthy, PL Jr., Ho VT, Storer B, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study. Blood 120:733a, 2012

61. Thakar MS, Logan BR, Pasquini MC, McCarthy PL Jr, Ho VT, Cooke KR, Zhu X, RIZZO JD, Sorror ML. The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases. Blood 120:737a, 2012

62. Eckrich MJ, Le-Rademacher J, RIZZO JD, Baker KS, Bhatla D, Buchbinder DK, Cooke KR, Duerst R, Gilman A, Frangoul H, Kapoor N, Kernan NA, Verneris M, Eapen M. The Effect of Transplant Center Characteristics on Survival After Pediatric Hematopoietic Cell Transplantation. Blood 120:762a, 2012

63. Atallah E, Pedersen TL, Warlick ED, Dircks A, Weisdorf D, Horowitz MM, RIZZO JD. The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults >=65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries. Blood 120:1983a, 2012

64. Bredeson C, Le-Rademacher J, Zhu X, Burkart J, Kato K, Armstrong E, Sun Y, Smith A, Ho VT, McCarthy PL, Cooke KR, RIZZO JD, Pasquini MC, Improved Survival with Intraveneous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A CIBMTR Prospective Study. BMT Tandem Meetings, Salt Lake City, UT, USA, February 2013

65. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio M, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, RIZZO JD, Horowitz MM, Saber W. Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research. Blood 122:548, 2013

66. Knight JM, RIZZO JD, Logan BR, Wang T, Cole SW, Altered Genetic Transcription Profiles among Hematopoietic Stem Cell Transplant Recipients based on Socioeconomic Status. Invited oral paper presentation, American Psychosomatic Society, San Francisco, CA (3/2014)*Selected for press release

67. Knight JM, RIZZO JD, Logan BR, Wang T, Cole SW, Altered Genetic Transcription Profiles among Hematopoietic Stem Cell Transplant Recipients based on Socioeconomic Status. Oral paper presentation, Society of Biological Psychiatry, New York, NY (5/2014)

68. Wood W, Le-Rademacher J, Fei M, Logan BR, Syrjala K, Majhail NS, Wingard JR, Abidi MH, Geller NL, Wu J, RIZZO JD, Faber E, Jim H, Jacobsen PB, Horowitz MM, Lee SJ. Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Blood 124:206a, 2014.

69. Seftel MD, Neuberg D, Zhang MJ, Wang HL, Bergeron J, Couban S, DeAngelo DJ, de Lima MJ, Devine SM, Eapen M, Horowitz MM, Pasquini MC, RIZZO JD, Saber W, Sallan SE, Sandmaier BM, Weisdorf DJ. Superiority of Pediatric Chemotherapy over 37 Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts. Blood 124:319a, 2014.

70. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Switzer GE, Riches ML, RIZZO JD, Anderlini P, Leitman SF, Varni JW, Hays A, Kobusingye H, Besser RM, Miller JP, Drexler RJ, King RJ, Horowitz MM, Navarro WH, Confer DL. Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe). Blood 124:3847a, 2014.

71. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai PR, Switzer GE, Riches ML, RIZZO JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP Drexler RJ, King RJ, Horowitz MM, Confer DL. Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe). (Oral) Biol Blood Marrow Transplant, 21:S41 - S42, 2015.

72. Knight J, Cole S, Logan BR, Wang T, RIZZO JD Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences. (Oral) Biol Blood Marrow Transplant, 21:S76 - S77, 2015.

73. Denzen EM, Murphy EA, Baker KS, Abetti B, Jahagirdar B, Kamani NR, RIZZO JD, Saber W, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS. Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study. (Oral) Biol Blood Marrow Transplant, 21:S174 - S175, 2015.

74. Dhakal B, Martens M, Kapke J, D'Souza A, Pasquini MC, Saber W, Hamadani M, Drobyski W, RIZZO JD, Horowitz MM, Zhang MJ, Hari PN. Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen. (Oral) Biol Blood Marrow Transplant, 21: S278 - S279, 2015.

75. Ehrhardt MJ, Brazauskas R, He W, RIZZO JD, Shaw BE, Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Paper Presentation, 14th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Arlington VA, June, 2015.

76. Knight JM, Martens M, Syrjala KL Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim H, Wingard JR, Horowitz MM, Majhail NS, Abidi MH, Geller NL, Fei M, Wu J, RIZZO JD. Pre-transplant health-related quality of life factors as predictors of outcomes following hematopoietic cell transplantation: A study from the BMT CTN 0902 trial. Oral Presentation, 2015 World Congress of Psycho-Oncology, Washington, DC, USA, July 28 – August 1, 2015.

77. Syrjala KL, Sutton SK, Yi JC, Jim HSL, Knight JM, Wood WA, Jacobsen PB, Majhail NS, Abidi MH, Wingard JR, Horowitz MM, Rizzo JD, Le-Rademacher J, Wu J, Lee SJ. Cancer and Treatment Distress Measurement over Time in a Multicenter Cohort of Hematopoietic Cell Transplantation (HCT) Recipients (BMT CTN 0902). Psycho-Oncology, 2015, 24 Suppl 2:84-85.

78. Knight J, Martens M, Syrjala K, Le-Rademacher J, Logan BR, Lee S, Jacobsen P, Wood W, Jim H, Wingard J, Horowitz M, Majhail N, Abidi M, Geller N, Fei M, Wu J, Rizzo JD. Pre-transplant health-related quality of life factors as predictors of outcomes following hematopoietic cell transplantation: A study from the BMT CTN 0902 trial. Psycho-Oncology, 2015, 24 Suppl 2:99.

79. D'Souza A, Millard HR, Knight JM, Brazauskas R, Vogel J, Mattila D, Flynn K, Lee SL, Horowitz MM, Rizzo JD, Shaw BE. Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults. Blood 2017 130:3447.

80. Chhabra S, Hari P, Visotcky A, Shah NN, Rizzo JD, Saber W, D'Souza A, Dhakal B, Anshu A, Thompson R, Fenske TS, Shaw BE, Drobyski WR, Pasquini MC, Hamadani M. Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study. Blood 2017 130:1974

81. Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Hillard CJ, Rizzo JD, Raison CL, D’Souza A, Coe CL, Drobyski WR. Inflammation and the brain: tocilizumab may redefine our understanding of depression and related symptoms in the medically ill. Oral Paper Presentation, Academy of Consultation Liaison Psychiatry, Orlando, FL (11/2018)

82. Knight J.M., Rizzo JD. Hari P., D’Souza A., Logan B.R., Giles K.E., Hamadani M., Chhabra S., Dhakal B., Shah N., & Cole S.W. (2018) Translational psycho-oncology: Neurally regulating cancer through propranolol by inhibiting stress-related gene expression profiles associated with adverse cancer outcomes. Academy of Consultation Liaison Psychiatry. Orlando, FL. November 16, 2018.

1. Jim HSL, Syrjala KL, RIZZO JD. Supportive care of hematopoietic cell transplant patients. Biol Blood Marrow Transplant 18:S12-S16, 2012.